1. Home
  2. CNTB vs STBX Comparison

CNTB vs STBX Comparison

Compare CNTB & STBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • STBX
  • Stock Information
  • Founded
  • CNTB 2012
  • STBX 2019
  • Country
  • CNTB United States
  • STBX Malaysia
  • Employees
  • CNTB N/A
  • STBX N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • STBX Advertising
  • Sector
  • CNTB Health Care
  • STBX Consumer Discretionary
  • Exchange
  • CNTB Nasdaq
  • STBX Nasdaq
  • Market Cap
  • CNTB 55.2M
  • STBX 59.7M
  • IPO Year
  • CNTB 2021
  • STBX 2022
  • Fundamental
  • Price
  • CNTB $0.87
  • STBX $0.21
  • Analyst Decision
  • CNTB Strong Buy
  • STBX
  • Analyst Count
  • CNTB 1
  • STBX 0
  • Target Price
  • CNTB $8.00
  • STBX N/A
  • AVG Volume (30 Days)
  • CNTB 22.8K
  • STBX 7.0M
  • Earning Date
  • CNTB 04-15-2025
  • STBX 02-28-2025
  • Dividend Yield
  • CNTB N/A
  • STBX N/A
  • EPS Growth
  • CNTB N/A
  • STBX N/A
  • EPS
  • CNTB N/A
  • STBX N/A
  • Revenue
  • CNTB $24,116,000.00
  • STBX $6,174,236.00
  • Revenue This Year
  • CNTB N/A
  • STBX N/A
  • Revenue Next Year
  • CNTB $63.90
  • STBX N/A
  • P/E Ratio
  • CNTB N/A
  • STBX N/A
  • Revenue Growth
  • CNTB N/A
  • STBX 48.08
  • 52 Week Low
  • CNTB $0.77
  • STBX $0.19
  • 52 Week High
  • CNTB $2.66
  • STBX $5.28
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 37.85
  • STBX 20.36
  • Support Level
  • CNTB $0.91
  • STBX $0.19
  • Resistance Level
  • CNTB $0.95
  • STBX $0.25
  • Average True Range (ATR)
  • CNTB 0.08
  • STBX 0.04
  • MACD
  • CNTB -0.01
  • STBX 0.03
  • Stochastic Oscillator
  • CNTB 27.95
  • STBX 6.85

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About STBX Starbox Group Holdings Ltd.

Starbox Group Holdings Ltd engages in developing cash rebate, digital advertising, and payment solution business ecosystem targeting micro, small, and medium enterprises. Through the firm's subsidiaries in Malaysia, it connects retail merchants with retail shoppers to facilitate transactions through cash rebates offered by retail merchants, provide digital advertising services to advertisers, and provide payment solution services to merchants. Substantially all of its current operations are located in Malaysia. It operates in five segments include Cash rebate, payment solution, and media booking, Advertising services, Software licensing and Production services, Marketing and Promotional campaign services segment.

Share on Social Networks: